Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.

F Waagstein, A Hjalmarson, E Varnauskas, I Wallentin

Adrenergic beta-blocking agents were given to 7 patients with advanced congestive cardiomyopathy who had tachycardia at rest (98 plus or minus 13 beats/min). The patients were on beta-adrenergic receptor blockade for 2 to 12 months (average 5-4 months). One patient was given alprenolol 50 mg twice daily and the other patients were given practolol 50 to 400 mg twice daily. Virus infection had occurred in 6 of the patients before the onset of symptoms of cardiac disease. All patients were in a steady state or were progressively deteriorating at the start of beta-adrenergic receptor blockade. Conventional treatment with digitalis and diuretics was unaltered or reduced during treatment with beta-blocking agents. An improvement was seen in their clinical condition shortly after administration of the drugs. Continued treatment resulted in an increase in physical working capacity and a reduction of heart size. Noninvasive investigations including phonocardiogram, carotid pulse curve, apex cardiogram, and echocardiogram showed improved ventricular function in all cases. The present study indicates that adrenergic beta-blocking agents can improve heart function in at lease some patients with congestive cardiomyopathy. Furthermore, it is suggested that increased catecholamine activity may be an important factor for the development of this disease, as has been shown in animal experiments.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Swedberg, K. (2009). {beta}-Blockers in worsening heart failure: good or bad?. Eur Heart J 30: 2177-2179 [Full Text]  
• Omerovic, E. (2009). Did Jesus die of a 'broken heart'?. Eur J Heart Fail 11: 729-731 [Full Text]  
• Braunwald, E. (2009). Adventures in Cardiovascular Research. Circulation 120: 170-180 [Abstract] [Full Text]  
• Franceschi, F, Deharo, J-C, Giorgi, R, By, Y, Monserrat, C, Condo, J, Ibrahim, Z, Saadjian, A, Guieu, R (2009). Peripheral plasma adenosine release in patients with chronic heart failure. Heart 95: 651-655 [Abstract] [Full Text]  
• Penn, R. B. (2009). Agonizing over agonism: Should asthmatics turn their {beta}-receptors on or off?. Proc. Natl. Acad. Sci. USA 106: 2095-2096 [Full Text]  
• Kim, I.-M., Tilley, D. G., Chen, J., Salazar, N. C., Whalen, E. J., Violin, J. D., Rockman, H. A. (2008). {beta}-Blockers alprenolol and carvedilol stimulate {beta}-arrestin-mediated EGFR transactivation. Proc. Natl. Acad. Sci. USA 105: 14555-14560 [Abstract] [Full Text]  
• Wisler, J. W., DeWire, S. M., Whalen, E. J., Violin, J. D., Drake, M. T., Ahn, S., Shenoy, S. K., Lefkowitz, R. J. (2007). A unique mechanism of beta-blocker action: Carvedilol stimulates beta-arrestin signaling. Proc. Natl. Acad. Sci. USA 104: 16657-16662 [Abstract] [Full Text]  
• Kasama, S., Toyama, T., Hatori, T., Sumino, H., Kumakura, H., Takayama, Y., Ichikawa, S., Suzuki, T., Kurabayashi, M. (2007). Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol. Eur Heart J 0: ehm048v1-7 [Abstract] [Full Text]  
• Lechat, P. (2006). The evolution of heart failure management over recent decades: from CONSENSUS to CIBIS. Eur Heart J Suppl 8: C5-C12 [Abstract] [Full Text]  
• Funck-Brentano, C. (2006). Beta-blockade in CHF: from contraindication to indication. Eur Heart J Suppl 8: C19-C27 [Abstract] [Full Text]  
• Ponikowski, P. (2006). Rationale and design of CIBIS III. Eur Heart J Suppl 8: C35-C42 [Abstract] [Full Text]  
• Molenaar, P., Christ, T., Ravens, U., Kaumann, A. (2006). Carvedilol blocks {beta}2- more than {beta}1-adrenoceptors in human heart. Cardiovasc Res 69: 128-139 [Abstract] [Full Text]  
• Task Force Members, , Lopez-Sendo, J., Swedberg, K., McMurray, J., Tamargo, J., Maggioni, A. P., Dargie, H., Tendera, M., Waagstein, F., Kjekshus, J., Lechat, P., Pedersen, C. T., ESC Committee for Practice Guidelines, , Priori, S. G., Alonso Garcia, M. A., Blanc, J.-J., Budaj, A., Cowie, M., Dean, V., Deckers, J., Fernandez Burgos, E., Lekakis, J., Lindahl, B., Mazzotta, G., McGregor, K., Morais, J., Oto, A., Smiseth, O. A., Document Reviewers, , Alonso Garcia, M. A., Ardissino, D., Avendano, C., Lundqvist, C. B., ment, D. C., Drexler, H., Ferrari, R., Fox, K. A., Julian, D., Kearney, P., Klein, W., ber, L. K., Mancia, G., Nieminen, M., Ruzyllo, W., Simoons, M., Thygesen, K., Tognoni, G., Tritto, I., Wallentin, L. (2004). Expert consensus document on {beta}-adrenergic receptor blockers: The Task Force on Beta-Blockers of the European Society of Cardiology. Eur Heart J 25: 1341-1362 [Full Text]  
• Chatterjee, K. (2004). The Fear of {beta}-Blocker Therapy in Heart Failure: Time to Forget. Arch Intern Med 164: 1370-1371 [Full Text]  
• Omerovic, E., Bollano, E., Soussi, B., Waagstein, F. (2003). Selective {beta}1-blockade attenuates post-infarct remodelling without improvement in myocardial energy metabolism and function in rats with heart failure. Eur J Heart Fail 5: 725-732 [Abstract] [Full Text]  
• Lohse, M. J., Engelhardt, S., Eschenhagen, T. (2003). What Is the Role of {beta}-Adrenergic Signaling in Heart Failure?. Circ. Res. 93: 896-906 [Abstract] [Full Text]  
• Toyama, T., Hoshizaki, H., Seki, R., Isobe, N., Adachi, H., Naito, S., Oshima, S., Taniguchi, K. (2003). Efficacy of Carvedilol Treatment on Cardiac Function and Cardiac Sympathetic Nerve Activity in Patients with Dilated Cardiomyopathy: Comparison with Metoprolol Therapy. JNM 44: 1604-1611 [Abstract] [Full Text]  
• Plank, D. M., Yatani, A., Ritsu, H., Witt, S., Glascock, B., Lalli, M. J., Periasamy, M., Fiset, C., Benkusky, N., Valdivia, H. H., Sussman, M. A. (2003). Calcium dynamics in the failing heart: restoration by {beta}-adrenergic receptor blockade. Am. J. Physiol. Heart Circ. Physiol. 285: H305-H315 [Abstract] [Full Text]  
• Tangeman, H. J, Patterson, J H. (2003). Extended-Release Metoprolol Succinate in Chronic Heart Failure. The Annals of Pharmacotherapy 37: 701-710 [Abstract] [Full Text]  
• Gheorghiade, M., Colucci, W. S., Swedberg, K. (2003). {beta}-Blockers in Chronic Heart Failure. Circulation 107: 1570-1575 [Full Text]  
• Goldstein, D. S., Robertson, D., Esler, M., Straus, S. E., Eisenhofer, G. (2002). Dysautonomias: Clinical Disorders of the Autonomic Nervous System. ANN INTERN MED 137: 753-763 [Abstract] [Full Text]  
• Soler-Soler, J., Garcia-Dorado, D. (2002). How to best to counteract the enemies? By blocking neurohormonal activation. Eur Heart J Suppl 4: G45-G50 [Abstract]  
• Kasama, S., Toyama, T., Hoshizaki, H., Oshima, S., Taniguchi, K., Suzuki, T., Kurabayashi, M. (2002). Dobutamine Gated Blood Pool Scintigraphy Predicts the Improvement of Cardiac Sympathetic Nerve Activity, Cardiac Function, and Symptoms After Treatment in Patients With Dilated Cardiomyopathy*. Chest 122: 542-548 [Abstract] [Full Text]  
• Pritchett, A. M., Redfield, M. M. (2002). {beta}-Blockers: New Standard Therapy for Heart Failure. Mayo Clin Proc. 77: 839-846 [Abstract]  
• Poole-Wilson, P. A., Cleland, J. G.F., Di Lenarda, A., Hanrath, P., Komajda, M., Metra, M., Remme, W. J., Swedberg, K., Torp-Pedersen, C. (2002). Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET. Eur J Heart Fail 4: 321-329 [Abstract] [Full Text]  
• Andreka, P., Aiyar, N., Olson, L. C., Wei, J. Q., Turner, M. S., Webster, K. A., Ohlstein, E. H., Bishopric, N. H. (2002). Bucindolol Displays Intrinsic Sympathomimetic Activity in Human Myocardium. Circulation 105: 2429-2434 [Abstract] [Full Text]  
• Foody, J. M., Farrell, M. H., Krumholz, H. M. (2002). {beta}-Blocker Therapy in Heart Failure: Scientific Review. JAMA 287: 883-889 [Abstract] [Full Text]  
• Frishman, W. H. (2001). Update in Cardiology. ANN INTERN MED 135: 439-446 [Full Text]  
• Coumel, P., Wilde, A. A.M. (2001). Learning From Mistakes: The Case of Clinical Electrophysiology: A Perspective on Evidence-Based Rhythmology. Circulation 104: 845-847 [Full Text]  
• Brophy, J. M., Joseph, L., Rouleau, J. L. (2001). {beta}-Blockers in Congestive Heart Failure: A Bayesian Meta-Analysis. ANN INTERN MED 134: 550-560 [Abstract] [Full Text]  
• Gomberg-Maitland, M., Baran, D. A., Fuster, V. (2001). Treatment of Congestive Heart Failure: Guidelines for the Primary Care Physician and the Heart Failure Specialist. Arch Intern Med 161: 342-352 [Abstract] [Full Text]  
• Ohtsuka, T., Hamada, M., Hiasa, G., Sasaki, O., Suzuki, M., Hara, Y., Shigematsu, Y., Hiwada, K. (2001). Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy. J Am Coll Cardiol 37: 412-417 [Abstract] [Full Text]  
• Maggioni, A. P. (2001). HEART FAILURE: Treatment strategies for heart failure: {beta} blockers and antiarrhythmics. Heart 85: 97-103 [Full Text]  
• Groenning, B. A., Nilsson, J. C., Sondergaard, L., Fritz-Hansen, T., Larsson, H. B. W., Hildebrandt, P. R. (2000). Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure. J Am Coll Cardiol 36: 2072-2080 [Abstract] [Full Text]  
• Borjesson, M, Magnusson, Y, Hjalmarson, A, Andersson, B (2000). A novel polymorphism in the gene coding for the beta1-adrenergic receptor associated with survival in patients with heart failure. Eur Heart J 21: 1853-1858 [Abstract]  
• Swedberg, K. (2000). Importance of neuroendocrine activation in chronic heart failure. Impact on treatment strategies. Eur J Heart Fail 2: 229-233 [Full Text]  
• Wei, S., Chow, L. T. C., Sanderson, J. E. (2000). Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction. J Am Coll Cardiol 36: 276-281 [Abstract] [Full Text]  
• Genth-Zotz, S., Zotz, R. J., Sigmund, M., Hanrath, P., Hartmann, D., Bohm, M., Waagstein, F., Treese, N., Meyer, J., Darius, H. (2000). MIC trial: metoprolol in patients with mild to moderate heart failure: effects on ventricular function and cardiopulmonary exercise testing. Eur J Heart Fail 2: 175-181 [Abstract] [Full Text]  
• Bristow, M. R. (2000). {beta}-Adrenergic Receptor Blockade in Chronic Heart Failure. Circulation 101: 558-569 [Full Text]  
• Kukin, M. L., Mannino, M. M., Freudenberger, R. S., Kalman, J., Buchholz-Varley, C., Ocampo, O. (2000). Hemodynamic comparison of twice daily metoprolol tartrate with once daily metoprolol succinate in congestive heart failure. J Am Coll Cardiol 35: 45-50 [Abstract] [Full Text]  
• Fagerberg, B (1999). The merit of beta1-blockade in heart failure. Eur Heart J 20: 1761-1763  
• Sanderson, J. E., Chan, S. K. W., Yip, G., Yeung, L. Y. C., Chan, K. W., Raymond, K., Woo, K. S. (1999). Beta-blockade in heart failure: A comparison of carvedilol with metoprolol. J Am Coll Cardiol 34: 1522-1528 [Abstract] [Full Text]  
• Davies, C.H., Bashir, Y. (1999). Beta-blockers for heart failure-time to think the unthinkable?. QJM 92: 673-678 [Full Text]  
• Kim, M. H., Devlin, W. H., Das, S. K., Petrusha, J., Montgomery, D., Starling, M. R. (1999). Effects of {beta}-Adrenergic Blocking Therapy on Left Ventricular Diastolic Relaxation Properties in Patients With Dilated Cardiomyopathy. Circulation 100: 729-735 [Abstract] [Full Text]  
• Kukin, M. L., Kalman, J., Charney, R. H., Levy, D. K., Buchholz-Varley, C., Ocampo, O. N., Eng, C. (1999). Prospective, Randomized Comparison of Effect of Long-Term Treatment With Metoprolol or Carvedilol on Symptoms, Exercise, Ejection Fraction, and Oxidative Stress in Heart Failure. Circulation 99: 2645-2651 [Abstract] [Full Text]  
• van Veldhuisen, D.J., Charlesworth, A., Crijns, H.J.G.M., Lie, K.I., Hampton, J.R. (1999). Differences in drug treatment of chronic heart failure between European countries. Eur Heart J 20: 666-672 [Abstract]  
• Macdonald, P. S., Keogh, A. M., Aboyoun, C. L., Lund, M., Amor, R., McCaffrey, D. J. (1999). Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure. J Am Coll Cardiol 33: 924-931 [Abstract] [Full Text]  
• Pepper, G. S., Lee, R. W. (1999). Sympathetic Activation in Heart Failure and Its Treatment With {beta}-Blockade. Arch Intern Med 159: 225-234 [Abstract] [Full Text]  
• Frishman, W. H. (1998). Carvedilol. NEJM 339: 1759-1765 [Full Text]  
• Luchner, A., Burnett, J. C. Jr., Jougasaki, M., Hense, H.-W., Riegger, G.u. A. J., Schunkert, H. (1998). Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study. J Am Coll Cardiol 32: 1839-1844 [Abstract] [Full Text]  
• Sakata, K., Shirotani, M., Yoshida, H., Kurata, C. (1998). Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential hypertension. J Am Coll Cardiol 32: 438-443 [Abstract] [Full Text]  
• Yamada, T, Fukunami, M, Shimonagata, T, Kumagai, K, Kim, J, Sanada, S, Ogita, H, Hori, M, Hoki, N (1998). Prediction of the effectiveness of long term beta  blocker treatment for dilated cardiomyopathy by signal averaged electrocardiography. Heart 79: 256-261 [Abstract] [Full Text]  
• Steeds, R. P, Channer, K. S (1998). Drug treatment in heart failure. BMJ 316: 567-568 [Full Text]  
• Sanderson, J E, Chan, S K W, Yu, C M, Yeung, L Y C, Chan, W M, Raymond, K, Chan, K W, Woo, K S (1998). beta Blockers in heart failure: a comparison of a vasodilating beta  blocker with metoprolol. Heart 79: 86-92 [Abstract] [Full Text]  
• Paulus, W. J., Kastner, S., Pujadas, P., Shah, A. M., Drexler, H., Vanderheyden, M. (1997). Left Ventricular Contractile Effects of Inducible Nitric Oxide Synthase in the Human Allograft. Circulation 96: 3436-3442 [Abstract] [Full Text]  
• Kukin, M. L, Kalman, J., Mannino, M. M, Buchholz-Varley, C., Ocampo, O. (1997). beta Blockade in congestive heart failure: persistent adverse haemodynamic effects during chronic treatment with subsequent doses. Heart 78: 444-449 [Abstract] [Full Text]  
• Funaya, H., Kitakaze, M., Node, K., Minamino, T., Komamura, K., Hori, M. (1997). Plasma Adenosine Levels Increase in Patients With Chronic Heart Failure. Circulation 95: 1363-1365 [Abstract] [Full Text]  
• Andersson, B., Caidahl, K., di Lenarda, A., Warren, S. E., Goss, F., Waldenstrom, A., Persson, S., Wallentin, I., Hjalmarson, A., Waagstein, F. (1996). Changes in Early and Late Diastolic Filling Patterns Induced by Long-term Adrenergic ß-Blockade in Patients With Idiopathic Dilated Cardiomyopathy. Circulation 94: 673-682 [Abstract] [Full Text]  
• Yamakawa, H., Takeuchi, M., Takaoka, H., Hata, K., Mori, M., Yokoyama, M. (1996). Negative Chronotropic Effect of ß-Blockade Therapy Reduces Myocardial Oxygen Expenditure for Nonmechanical Work. Circulation 94: 340-345 [Abstract] [Full Text]  
• Goldstein, S. (1996). {beta}-Blockers in Hypertensive and Coronary Heart Disease. Arch Intern Med 156: 1267-1276 [Abstract]  
• Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., Shusterman, N. H., The U.S. Carvedilol Heart Failure Study Group, (1996). The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure. NEJM 334: 1349-1355 [Abstract] [Full Text]  
• Pfeffer, M. A., Stevenson, L. W. (1996). {beta}-Adrenergic Blockers and Survival in Heart Failure. NEJM 334: 1396-1397 [Full Text]  
• Sackner-Bernstein, J. D., Mancini, D. M. (1995). Rationale for Treatment of Patients With Chronic Heart Failure With Adrenergic Blockade. JAMA 274: 1462-1467 [Abstract]  
• COMMITTEE MEMBERS, , WILLIAMS, J. F. Jr, BRISTOW, M. R., FOWLER, M. B., FRANCIS, G. S., GARSON, A. Jr, GERSH, B. J., HAMMER, D. F., HLATKY, M. A., LEIER, C. V., PACKER, M., PITT, B., ULLYOT, D. J., WEXLER, L. F., WINTERS, W. L. Jr, TASK FORCE MEMBERS, , RITCHIE, J. L., CHEITLIN, M. D., EAGLE, K. A., GARDNER, T. J., GARSON, A. Jr, GIBBONS, R. J., LEWIS, R. P., O'ROURKE, R. A., RYAN, T. J. (1995). Guidelines for the Evaluation and Management of Heart Failure : Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). Circulation 92: 2764-2784 [Full Text]  
• Krum, H., Sackner-Bernstein, J. D., Goldsmith, R. L., Kukin, M. L., Schwartz, B., Penn, J., Medina, N., Yushak, M., Horn, E., Katz, S. D., Levin, H. R., Neuberg, G. W., DeLong, G., Packer, M. (1995). Double-Blind, Placebo-Controlled Study of the Long-term Efficacy of Carvedilol in Patients With Severe Chronic Heart Failure. Circulation 92: 1499-1506 [Abstract] [Full Text]  
• Dargie, H J, McMurray, J J V (1994). Fortnightly Review: Diagnosis and management of heart failure. BMJ 308: 321-328 [Abstract] [Full Text]